Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 2004;90:241-242; doi:10.1136/hrt.2003.021295
Copyright © 2004 BMJ Publishing Group Ltd & British Cardiovascular Society
Heart 2004;90:241-242
© 2004 by BMJ Publishing Group & British Cardiac Society

EDITORIAL

Implantable cardioverter-defibrillators for children and young adolescents: mortality benefit confirmed—what’s next?

S F Sears1, J B Conti2

1 Department of Clinical Health Psychology, University of Florida, Gainesville, Florida, USA
2 Division of Cardiovascular Medicine, University of Florida

Correspondence to:
Correspondence to:
Samuel F Sears
PhD, University of Florida, Department of Clinical & Health Psychology, Box 100165 UF Health Science Center, Gainesville, FL 32610, USA; ssears@hp.ufl.edu


The implantable cardioverter-defibrillator can present significant psychological difficulties for some younger patients, not least because of increased lifestyle disruption and the likely experience of shock

The first 150 words of the full text of this article appear below.

The implantable cardioverter-defibrillator (ICD) is the treatment of choice for potentially life threatening ventricular arrhythmias. Consistent with the adult clinical trial data for both primary and secondary prevention, Gradaus and colleagues1 followed children and young adolescents with ICDs for an average of four years and found that the children’s total survival was excellent (95.8%). The demonstrated mortality benefit demonstrated by Gradaus and colleagues1 in this issue of Heart allows us to turn our attention to psychosocial issues and quality of life (QoL) of young ICD patients.2

We reported that younger age and greater frequency of ICD firings were the two most commonly reported ICD specific risk factors for psychological distress.3 Younger patients (50 years and younger) may experience greater problems because of increased lifestyle disruption and distressing social comparisons.2 In addition to adjusting to the risk of potentially life threatening arrhythmias, young patients must deal with the presence of the . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Berul, C. I., Van Hare, G. F., Kertesz, N. J., Dubin, A. M., Cecchin, F., Collins, K. K., Cannon, B. C., Alexander, M. E., Triedman, J. K., Walsh, E. P., Friedman, R. A. (2008). Results of a Multicenter Retrospective Implantable Cardioverter-Defibrillator Registry of Pediatric and Congenital Heart Disease Patients. J Am Coll Cardiol 51: 1685-1691 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.